Intratumoral therapy with interferon-α in a locoregional advanced malignant blue nevus: A brief communication

Journal of Immunotherapy

Volumn 33, Issue 1, 2010, Pages 92-95

  Moos, Roger Von ^a   Schaffner, Reto ^b   Cathomas, Richard ^a   Grimm, Birgit ^a  

^a KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^b Facharzt FMH Dermatologie und Venerologie ^*  (Switzerland)

Author keywords

Interferon alpha 2b; Intralesional; Malignant blue nevus; Melanoma

Indexed keywords

ALPHA2B INTERFERON; CARBOPLATIN; CISPLATIN; DACARBAZINE; PACLITAXEL; SORAFENIB; VINBLASTINE;

ADULT; ADVANCED CANCER; ARTICLE; BLUE NEVUS; BUTTOCK; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; HUMAN; HUMAN TISSUE; MAINTENANCE THERAPY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; VOCATIONAL REHABILITATION;

ADULT; ANTINEOPLASTIC AGENTS; HUMANS; INTERFERON-ALPHA; MALE; NEOPLASM RECURRENCE, LOCAL; NEVUS, BLUE; SKIN NEOPLASMS;

EID: 74349121632     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3181b29133     Document Type: Article

References (11)

1. Magro CM, Crowson AN, Mihm MC. Unusual variants of malignant melanoma. Mod Pathol. 2006;19(suppl 2):S41-S70.
2. Requena L, Carlson JA. Melanoma arising from blue nevus. In: LeBoit PE, Burg G, Weedon D, et al. eds. Pathology and genetics of skin tumors. Lyon, France: IARC Press; 2006:79-82.
3. Calista D, Schianchi S, Landi C. Malignant blue nevus of the scalp. Int J Dermatol. 1998;37:126-127.
4. Mehregan DA, Gibson LE, Mehregan AH. Malignant blue nevus: a report of eight cases. J Dermatol Sci. 1992;4:185-192.
5. Legha SS, Ring S, Papadopoulos N, et al. A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma. Cancer. 1989;64:2024-2029.
6. Flaherty KT, Schiller J, Schuchter LM, et al. A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel. Clin Cancer Res. 2008;14: 4836-4842.
7. von Wussow P, Block B, Hartmann F, et al. Intralesional interferon-alpha therapy in advanced malignant melanoma. Cancer. 1988;61:1071-1074.
8. Kirkwood JM. Studies of interferons in the therapy of melanoma. Semin Oncol. 1991;18:83-90.
9. Kirkwood JM, Ernstoff MS. Role of interferons in the therapy of melanoma. J Invest Dermatol. 1990;95:180S-184S.
10. Alpsoy E, Yilmaz E, Basaran E, et al. Comparison of the effects of intralesional interferon alfa-2a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma. J Dermatol. 1996;23:394-396.
11. Edwards L, Berman B, Rapini RP, et al. Treatment of cutaneous squamous cell carcinomas by intralesional interfer-on alfa-2b therapy. Arch Dermatol. 1992;128:1486-1489.